Evoluent Pharmaceuticals Private Limited, a active private limited company, was established on 29 October 2015 in Palace Guttahalli, Karnataka, India. Engaging in retailers within the trade sector, it holds CIN: U24230KA2015PTC083741. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ranganathaiah Chethan (Additional Director), Belavanur Rudrappa Manjunathappa (Director), Priyanka Kotrappa (Additional Director). Past directors included Suresh Gowda. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at No 01, Nagappa Street, Vinayaka Circle 2Nd Main Road, Palace Guttahalli, Karnataka, 560003.
U24230KA2015PTC083741
083741
29 October 2015
₹1.00 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Evoluent Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranganathaiah Chethan | Additional Director | 11 Feb 2019 | Current |
| Belavanur Rudrappa Manjunathappa | Director | 29 Oct 2015 | Current |
| Priyanka Kotrappa | Additional Director | 23 Nov 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Nov 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Evoluent Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Evoluent Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Evoluent Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Evoluent Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evoluent Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Evoluent Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
Progress on Evoluent Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Bangalore. was documented.
Ranganathaiah Chethan was appointed as a Additional Director was appointed as a Additional Director on 11 Feb 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.
Progress on Priyanka Kotrappa was appointed as a Additional Director was appointed as a Additional Director on 23 Nov 2017 & has been associated with this company since 8 years 1 month . was documented.
Progress on Belavanur Rudrappa Manjunathappa was appointed as a Director was appointed as a Director on 29 Oct 2015 & has been associated with this company since 10 years 2 months . was documented.
The activity Evoluent Pharmaceuticals Private Limited was registered on 29 Oct 2015 with Roc Bangalore & aged 10 years 2 months as per MCA records. was completed.
The CIN of Evoluent Pharmaceuticals Private Limited is U24230KA2015PTC083741.
Evoluent Pharmaceuticals Private Limited is headquartered at No 01, Nagappa Street, Vinayaka Circle 2Nd Main Road, Palace Guttahalli, Karnataka, 560003.
Evoluent Pharmaceuticals Private Limited was incorporated on 29 October 2015.
The current directors of Evoluent Pharmaceuticals Private Limited are
The primary industry of Evoluent Pharmaceuticals Private Limited is Trade.
Evoluent Pharmaceuticals Private Limited is unlisted.
The authorized capital of Evoluent Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Evoluent Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX